Home

  • New CEO Takes the Helm of Takeda: What’s Next?ByPatricia Van Arnum

    New CEO Takes the Helm of Takeda: What’s Next?
    By

    In a planned succession,Julie Kim took the helm at Takeda as President and CEO with former President and CEO Christophe Weber stepping down following a 12-year tenure. The company faces a transitional period as it seeks to return to growth. What’s the plan? By Patricia Van Arnum, Editorial Director, DCAT, pvanarnum@dcat.org Changing of the guardIn…


  • The State of the State: Continuous ManufacturingByPatricia Van Arnum

    The State of the State: Continuous Manufacturing
    By

    FDA’s Emerging Technology Program, a collaborative program between the agency and industry, aims to facilitate bio/pharma companies’ adoption of new manufacturing technologies, including continuous manufacturing. Where do things stand?


  • CDMO Insights: What’s Trending in the Injectable Drug Market?ByPatricia Van Arnum

    CDMO Insights: What’s Trending in the Injectable Drug Market?
    By

    GPL-1s for treating Type 2 diabetes and obesity have been a key growth driver for the bio/pharma industry as well as for CDMOs of injectables, but will the entry of oral GLP-1s and related drugs put a damper on growth prospects for injectables? What is the expected market penetration?


DCAT MEMBER COMPANY COMMUNITY

  • DCAT Awards Grants To Student Scientists at the 2026 Regeneron International Science & Engineering Fair   
    By

    The Drug, Chemical & Associated Technologies Association (DCAT) has awarded $30,000 in grants to student scientists of six projects who participated in the Regeneron International Science & Engineering Fair (Regeneron ISEF), the world’s largest international pre-college student science and engineering competition that took place in Phoenix, Arizona from May 9–15, 2026.   Owned and produced by the Society for Science, Regeneron…

  • ICYMI: Production to Prescription Podcast: A CDMO Roundtable: The Making of a Molecule: Peptide Synthesis 
    By

    The blockbuster success of the GLP-1 agonists and related drugs has renewed interest in peptide-based therapeutics, but how is the manufacturing technology evolving?  In the latest episode of the DCAT Value Chain Insights podcast, Production to Prescription, a roundtable of industry experts share their perspectives on the latest in peptide synthesis.   Solid-phase peptide synthesis (SPPS) is the dominant method in peptide synthesis, but other approaches, such…

  • New DCAT Member Company Alert
    By

    Welcome to the newest Member Companies in the Drug, Chemical & Associated Technologies Association (DCAT). DCAT is pleased to welcome the following companies to the DCAT Member Community. To view all DCAT Member Companies, visit the Member Directory at the DCAT website. From the May 8, 2026, issue of  DCAT Value Chain Insights: From the May…

  • People on the Move
    By

    Here are the latest moves and promotions of employees from the DCAT Member Company community. To submit a request to be included in People on the Move, click here. From the March 6, 2026, issue of DCAT Value Chain Insights: From the January 30, 2026, issue of DCAT Value Chain Insights: